Limbal Stem Cell Deficiency: Clinical Trials

11 trials for Limbal Stem Cell Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 11 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 5, Unknown 3, Recruiting 2, Active not recruiting 1
Phase 26Completed 3, Unknown 2, Recruiting 1

Follow Limbal Stem Cell Deficiency: new trials by email Literature Review of Limbal Stem Cell Deficiency trials Research Report on Limbal Stem Cell Deficiency

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
CSB-001 Ophthalmic Solution 0.1% - Limbal Stem Cell Deficiency
Phase 1RecruitingClaris Biotherapeutics, Inc.752024-05-152026-08-13
Treatment of LSCD With DM
transplantation of a Descemet's Membrane corneal onlay, partial LSCD, transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD - Limbal Stem-cell Deficiency, Congenital Aniridia
Phase 1CompletedUniversity of Minnesota192023-11-302026-01-08
Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency
FEMJA transplatation - Total Bilateral Limbal Cell Deficiency
Phase 1 / Phase 2RecruitingHospices Civils de Lyon402020-11-132025-12-16
Stem Cell Therapy for Limbal Stem Cell Deficiency
cLSC, Scleral contact lens (SCL) - Limbal Stem-cell Deficiency
Phase 1Active not recruitingUniversity of California, Los Angeles202020-09-302026-02-10
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
LSC2 - Limbal Stem Cell Deficiency
Phase 1 / Phase 2UnknownRHEACELL GmbH & Co. KG162019-07-042022-10-07
Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease
cultured autologous oral mucosal epithelial cell sheet - Limbal Stem Cell Deficiency
Phase 1 / Phase 2UnknownHe Eye Hospital72017-01-012017-01-10
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft, Cultivation of Limbal epithelial cells into a graft, CALEC Transplant - Limbal Stem Cell Deficiency
Phase 1 / Phase 2CompletedMassachusetts Eye and Ear Infirmary232016-08-012025-01-15
Cultivated Autologous Oral Mucosal Epithelial Transplantation
Cultivated oral mucosal epithelial cell transplantation - Limbal Stem Cell Deficiency
Phase 1UnknownChang Gung Memorial Hospital82016-03-012020-08-13
Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency
Mucosal cell sheet transplantation - Limbal Stem-cell Deficiency
Phase 1 / Phase 2CompletedSiriraj Hospital62013-04-172019-10-11
The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)
Amniotic Membrane Extract Eye Drop (AMEED) - Limbal Stem Cell Deficiency (LSCD)
Phase 1CompletedRoyan Institute102011-08-012016-01-07
Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients
Cultured limbal stem cells Transplantation - Limbal Stem Cell Deficiency
Phase 1 / Phase 2CompletedRoyan Institute102007-10-012011-07-15

Narrower conditions

Aniridia (1)  ·  Corneal Diseases (1)  ·  Corneal Injuries (1)  ·  Corneal Neovascularization (1)  ·  Corneal Opacity (1)  ·  Eye Injuries (1)

Broader conditions

Eye Diseases (11)  ·  Corneal Diseases (10)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniocerebral Trauma (1)  ·  Eye Abnormalities (1)  ·  Eye Diseases, Hereditary (1)  ·  Facial Injuries (1)  ·  Genetic Diseases, Inborn (1)  ·  Iris Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Transplantation (1)

Sponsors

Royan Institute (2)  ·  Chang Gung Memorial Hospital (1)  ·  Claris Biotherapeutics, Inc. (1)  ·  He Eye Hospital (1)  ·  Hospices Civils de Lyon (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  RHEACELL GmbH & Co. KG (1)  ·  Siriraj Hospital (1)  ·  University of California, Los Angeles (1)  ·  University of Minnesota (1)

Countries

United States (5)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Alireza Baradaran, MD (2)  ·  Marzieh Ebrahimi, PhD (2)  ·  Adisak Wongkajornsilp, M.D., Ph.D. (1)  ·  David Hui-Kang Ma, MD, PhD (1)  ·  Gerd U. Auffarth, Prof.Dr.med. (1)  ·  Hamid Gorabi, PhD (1)  ·  Hamid Gourabi, PhD (1)  ·  Hossein Baharvand, PhD (1)  ·  Maryam Momeni, MSc (1)  ·  Mitra Akbari, MD (1)  ·  Mohammadali Javadi, MD (1)  ·  Niloufar Shayan, MSc (1)  ·  Sophie Deng, MD, PhD (1)  ·  Stephen Kaufman, MD (1)  ·  Ula Jurkunas, MD (1)

Results publications

PMID 15377551, PMID 16458679, PMID 16989763, PMID 17251457, PMID 19373264, PMID 19458337, PMID 21097786, PMID 21571372, PMID 21652025, PMID 22850415, PMID 23087419, PMID 27824126, PMID 34620226, PMID 35922868, PMID 40038272, PMID 40152603, PMID 41503585

NIH funding

R01EY021797 (1)